Search

Your search keyword '"Ng, G. A."' showing total 1,371 results
Start Over Author "Ng, G. A."
1,371 results on '"Ng, G. A."'

101. Detection of copy number variations in epilepsy using exome data

Author

Tsuchida, N., Nakashima, M., Kato, M., Heyman, E., Inui, T., Haginoya, K., Watanabe, S., Chiyonobu, T., Morimoto, M., Ohta, M., Kumakura, A., Kubota, M., Kumagai, Y., Hamano, S.‐I., Lourenco, C.M., Yahaya, N.A., Chʼng, G.‐S., Ngu, L.‐H., Fattal‐Valevski, A., Weisz Hubshman, M., Orenstein, N., Marom, D., Cohen, L., Goldberg‐Stern, H., Uchiyama, Y., Imagawa, E., Mizuguchi, T., Takata, A., Miyake, N., Nakajima, H., Saitsu, H., Miyatake, S., and Matsumoto, N.

Published
2018
Full Text
View/download PDF

103. Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial

Author

Lobo, Melvin D., Ott, Christian, Sobotka, Paul A., Saxena, Manish, Stanton, Alice, Cockcroft, John R., Sulke, Neil, Dolan, Eamon, van der Giet, Markus, Hoyer, Joachim, Furniss, Stephen S., Foran, John P., Witkowski, Adam, Januszewicz, Andrzej, Schoors, Danny, Tsioufis, Konstantinos, Rensing, Benno J., Scott, Benjamin, Ng, G. André, and Schmieder, Roland E.

Published
2017
Full Text
View/download PDF

106. High prevalence of hepatitis A and B nonimmunity in pediatric liver transplant recipients.

Author

de St Maurice, Annabelle, Ng, G, Aryasomayajula, C, Liman, A, McDiarmid, SV, Venick, RS, and Wozniak, Laura J

Subjects
*LIVER transplantation, *DISEASE prevalence, *DISEASE risk factors, *HEPATITIS viruses, *HEPATITIS A
Abstract

Background: Pediatric liver transplant recipients are at increased risk of post‐transplant infections. The purpose of this study was to quantify hepatitis A and B non‐immunity based on antibody titers in liver transplant recipients. Methods: We conducted a retrospective chart review of 107 pediatric liver transplant recipients at a single medical center from 2000 to 2017. We compared hepatitis immune patients to non‐immune patients and studied response to vaccination in patients immunized post‐transplantation. Results: Eighty‐one percent of patients had pre‐transplant immunity to hepatitis A whereas 68% had pre‐transplant immunity to hepatitis B. Post‐transplant hepatitis B immunity decreased to 33% whereas post‐transplant hepatitis A immunity remained high at 82%. Older age and time since transplantation were significantly associated with hepatitis B non‐immunity. Most patients responded to doses post‐transplantation with 78% seroconversion following hepatitis A re‐immunization and 83% seroconversion following hepatitis B re‐immunization. Conclusions: Pediatric liver transplant recipients are at risk of hepatitis A and B non‐immunity, particularly with respect to hepatitis B. Boosters post‐transplant may improve immunity to hepatitis viruses. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

110. Machine learning in sudden cardiac death risk prediction: a systematic review

Author

Barker, Joseph, primary, Li, Xin, additional, Khavandi, Sarah, additional, Koeckerling, David, additional, Mavilakandy, Akash, additional, Pepper, Coral, additional, Bountziouka, Vasiliki, additional, Chen, Long, additional, Kotb, Ahmed, additional, Antoun, Ibrahim, additional, Mansir, John, additional, Smith-Byrne, Karl, additional, Schlindwein, Fernando S, additional, Dhutia, Harshil, additional, Tyukin, Ivan, additional, Nicolson, William B, additional, and Ng, G Andre, additional

Published
2022
Full Text
View/download PDF

111. Patient experience of very high power short duration radiofrequency ablation for atrial fibrillation under mild conscious sedation

Author

Chu, Gavin, primary, Calvert, Peter, additional, Sidhu, Bharat, additional, Mavilakandy, Akash, additional, Kotb, Ahmed, additional, Tovmassian, Lilith, additional, Kozhuharov, Nikola, additional, Biermé, Cédric, additional, Denham, Nathan, additional, Pius, Charlene, additional, O’Brien, Jim, additional, Ding, Wern Yew, additional, Luther, Vishal, additional, Snowdon, Richard L., additional, Ng, G. André, additional, and Gupta, Dhiraj, additional

Published
2022
Full Text
View/download PDF

117. 90 Atrial fibrillation virtual ward – a glimpse into the future of af care

Author

Kotb, Ahmed, primary, Armstrong, Suzanne, additional, Antoun, Ibrahim, additional, Koev, Ivelin, additional, Barker, Joseph, additional, Mavilakandy, Akash, additional, Vali, Zakariyya, additional, Li, Xin, additional, Lazdam, Merzaka, additional, Ibrahim, Mokhtar, additional, Sandilands, Alastair, additional, Chin, Shui Hao, additional, Somani, Riyaz, additional, and Ng, G. Andre, additional

Published
2022
Full Text
View/download PDF

119. 95 Safety and outcomes of very high-power short-duration ablation using 90w for pulmonary vein isolation in patients with atrial fibrillation: a real world observation study

Author

Mavilakandy, Akash, primary, Antoun, Ibrahim, additional, Kotb, Ahmed, additional, Barker, Joseph, additional, Koev, Ivelin M, additional, Sidhu, Bharat, additional, Vali, Zakariyya, additional, Pooranachandran, Vivetha, additional, Li, Xin, additional, and Ng, G. Andre, additional

Published
2022
Full Text
View/download PDF

122. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

Author

Li Bassi, G., Gibbons, K., Suen, J. Y., Dalton, H. J., White, N., Corley, A., Shrapnel, S., Hinton, S., Forsyth, S., Laffey, J. G., Fan, E., Fanning, J. P., Panigada, M., Bartlett, R., Brodie, D., Burrell, A., Chiumello, D., Elhazmi, A., Esperatti, M., Grasselli, G., Hodgson, C., Ichiba, S., Luna, C., Marwali, E., Merson, L., Murthy, S., Nichol, A., Ogino, M., Pelosi, P., Torres, A., P. Y., Ng, Fraser, J. F., Al-Dabbous, T., Alfoudri, H., Shamsah, M., Elapavaluru, S., Berg, A., Horn, C., Mayasi, Y., Schroll, S., Meyer, D., Velazco, J., Ploskanych, L., Fikes, W., Bagewadi, R., Dao, M., White, H., Ehlers, A., Shalabi-McGuire, M., Witt, T., Grazioli, L., Lorini, L., Grandin, E. W., Nunez, J., Reyes, T., Obriain, D., Hunter, S., Ramanan, M., Affleck, J., Veerendra, H. H., Rai, S., Russell-Brown, J., Nourse, M., Joseph, M., Mitchell, B., Tenzer, M., Abe, R., Cho, H. J., Jeong, I. S., Rahman, N., Kakar, V., Brozzi, N., Mehkri, O., Krishnan, S., Duggal, A., Houltham, S., Graf, J., Diaz, R., Orrego, R., Delgado, C., Gonzalez, J., Sanchez, M. S., Piagnerelli, M., Sarrazin, J. V., Zabert, A. /P. G., Espinosa, L., Delgado, P., Delgado, V., Rincon, D. F. B., Yanten, A. M. M., Duque, M. B., Al-Hudaib, A., Callahan, M., Taufik, M. A., Wardoyo, E. Y., Gunawan, M., Trisnaningrum, N. S., Irawany, V., Rayhan, M., Pesenti, A., Zanella, A., Leone, M., Coppola, S., Colombo, S., Antonelli, M., Carelli, S., Grieco, D. L., Asaki, M., Hoshino, K., Salazar, L., Duarte, L., Laffey, J., Mcnicholas, B., Cosgrave, D., Mccaffrey, J., Bone, A., Hakeem, Y., Winearls, J., Tallott, M., Thomson, D., Arnold-Day, C., Cupido, J., Fanie, Z., Miller, M., Seymore, L., van Straaten, D., Hssain, A. A., Aliudin, J., Alqahtani, A. -R., Mohamed, K., Mohamed, A., Tan, D., Villanueva, J., Zaqout, A., Kurtzman, E., Ademi, A., Dobrita, A., El Aoudi, K., Segura, J., Giwangkancana, G., Ohshimo, S., Hitoshi, S., Osatnik, J., Joosten, A., Yang, M., Motos, A., Arancibia, F., Williams, V., Noel, A., Luque, N., Trung, T. H., Yacoub, S., Fantini, M., Garcia, R. N. J., Alvarez, E. C., Greti, A., Ceccato, A., Sanchez, A., Vazquez, A. L., Roche-Campo, F., Franch-Llasat, D., Tuazon, D., Amato, M., Cassimiro, L., Pola, F., Ribeiro, F., Fonseca, G., Dalton, H., Desai, M., Osborn, E., Deeb, H., Arcadipane, A., Martucci, G., Panarello, G., Vitiello, C., Bianco, C., Occhipinti, G., Rossetti, M., Cuffaro, R., Cho, S. -M., Shimizu, H., Moriyama, N., Kim, J. -B., Kitamura, N., Gebauer, J., Yokoyama, T., Al-Fares, A., Buabbas, S., Alamad, E., Alawadhi, F., Alawadi, K., Tanaka, H., Hashimoto, S., Yamazaki, M., T. -H., Oh, Epler, M., Forney, C., Kruse, L., Feister, J., Williamson, J., Grobengieser, K., Gnall, E., Golden, S., Caroline, M., Shapiro, T., Karaj, C., Thome, L., Sher, L., Vanderland, M., Welch, M., Mcdermott, S., Brain, M., Mineall, S., Kimura, D., Brazzi, L., Sales, G., Ogston, T., Nagpal, D., Fischer, K., Lorusso, R., Rangappa, R., Appu, A., Carton, E. G., Sen, A., Palacios, A., Rainey, D., Samoukoviv, G., Campisi, J., Durham, L., Neumann, E., Seefeldt, C., Falcucci, O., Emmrich, A., Guy, J., Johns, C., Potzner, K., Zimmermann, C., Espinal, A., Buchtele, N., Schwameis, M., Stecher, S. -S., Singh, D., Barnikel, M., Arenz, L., Zaaqoq, A., Galloway, L. A., Merley, C., Csete, M., Quesada, L., Saba, I., Kasugai, D., Hiraiwa, H., Tanaka, T., Purnama, Y., Dewayanti, S. R., Ardiyan, Juzar, D. A., Siagian, D., Chen, Y. -S., Ratsep, I., Oigus, G., Erikson, K., Post, A. -M., Enneveer, L., Sillaots, P., Manetta, F., Mihelis, E., Sarmiento, I. C., Narasimhan, M., Varrone, M., Komats, M., Garcia-Diaz, J., Harmon, C., Satyapriya, S. V., Bhatt, A., Mokadam, N. A., Uribe, A., Gonzalez, A., Shi, H., Mckeown, J., Pasek, J., Fiorda, J., Echeverria, M., Moreno, R., Zakhary, B., Cavana, M., Cucino, A., Foti, G., Giani, M., Russotto, V., Castagna, V., Dellamore, A., Navalesi, P., Shum, H. -P., Vuysteke, A., Usman, A., Acker, A., Smood, B., Mergler, B., Sertic, F., Subramanian, M., Sperry, A., Rizer, N., Burhan, E., Rasmin, M., Akmal, E., Sitompul, F., Lolong, N., Naivedh, B., Erickson, S., Barrett, P., Dean, D., Daugherty, J., Loforte, A., Khan, I., Abraar Quraishi, M., Desantis, O., So, D., Kandamby, D., Mandei, J. M., Natanael, H., Yudhalantang, E., Lantang, A., Wijaya, S. O., Jung, A., Ng, G., W. Y., Ng, Fang, S., Tabah, A., Ratcliffe, M., Duroux, M., Adachi, S., Nakao, S., Blanco, P., Prieto, A., Sanchez, J., Nicholson, M., Butt, W., Serratore, A., Delzoppo, C., Janin, P., Yarad, E., Totaro, R., Coles, J., Pujo, B., Balk, R., Vissing, A., Kapania, E., Hays, J., Fox, S., Yantosh, G., Mishin, P., Yuliarto, S., Hari Santoso, K., Djajalaksana, S., Fatoni, A. Z., Fukuda, M., Liu, K., Battaglini, D., Jimenez, J. F. M., Bastos, D., Gaiao, S., Rusmawatiningtyas, D., Buchner, J., Cho, Y. -J., Lee, S. H., Kawasaki, T., Munshi, L., Sakiyalak, P., Nitayavardhana, P., Seitz, T., Arora, R., Kent, D., Marino, D., Parwar, S., Cheng, A., Miller, J., Fujitani, S., Shimizu, N., Madhok, J., Owyang, C., Buscher, H., Reynolds, C., Maasikas, O., Beljantsev, A., Mihnovits, V., Akimoto, T., Aizawa, M., Horibe, K., Onodera, R., Young, M., George, T., Shekar, K., Mcguinness, N., Irvine, L., Flynn, B., Endo, T., Sugiyama, K., Shimizu, K., Exconde, K., Lussier, L., Lotz, G., Malfertheiner, M., Maier, L., Dreier, E., Kusumastuti, N. P., Mccloskey, C., Dabaliz, A. -A., Elshazly, T. B., Smith, J., Szuldrzynski, K. S., Bielanski, P., Wille, K., Parhar, K. K. S., Fiest, K. M., Codan, C., Shahid, A., Fayed, M., Evans, T., Garcia, R., Gutierrez, A., Song, T., Rose, R., Bennett, S., Richardson, D., Peek, G., Arora, L., Rappapport, K., Rudolph, K., Sibenaller, Z., Stout, L., Walter, A., Herr, D., Vedadi, N., Thompson, S., Sindt, L., Rajnic, S., Ewald, C., Hoffman, J., Ying, X., Kennedy, R., Griffee, M., Ciullo, A., Kida, Y., Roca, R. F., Riera, J. I., Contreras, S., Alegre, C., Kay, C., Fischer, I., Renner, E., Taniguci, H., Fraser, J., Bassi, G. L., Suen, J., Barnett, A., Pearse, I., Abbate, G., Hassan, H., Heinsar, S., Karnik, V. A., Ki, K., Oneill, H. F., Obonyo, N., Pimenta, L. P., Reid, J. D., Sato, K., Vuorinen, A., Wildi, K. S., Wood, E. S., Yerkovich, S., Lee, J., Plotkin, D., Citarella, B. W., Hartley, E., Lubis, B., Ikeyama, T., Bhaskar, B., Jung, J. -S., Mcguinness, S., Eastwood, G., Marta, S. R., Guarracino, F., Gerle, S., Coxon, E., Claro, B., Loverde, D., Patil, N., Parrini, V., Mcbride, A., Negaard, K., Ratsch, A., Abdelaziz, A., Uribe, J. D., Peris, A., Sanders, M., Emerson, D., Kamal, M., Povoa, P., Francis, R., Cherif, A., Joseph, S., Di Nardo, M., Heard, M., Kyle, K., Blackwell, R. A., Biston, P., Jeong, H. W., Smith, R., Prawira, Y., Montrucchio, G., Garcia, A. H., Salterain, N., Meyns, B., Moreno, M., Walia, R., Mehta, A., Schweda, A., Supriatna, M., Kirakli, C., Williams, M., Kim, K. H., Assad, A., Giraldo, E., Karolak, W., Balik, M., Pocock, E., Gajkowski, E., Masafumi, K., Barrett, N., Takeyama, Y., Park, S., Amin, F., Andriyani, F. M., Sudakevych, S., Vera, M., Cornejo, R., Schwarz, P., Mardini, A. C., de Paula, T., Neto, A. S., Villoldo, A., Colafranceschi, A. S., Iglesias, A. U., Granjean, J., Melro, L. M. G., Romualdo, G. F., Gaia, D., Souza, H., Galas, F., Mendiluce, R. M., Sosa, A., Martinez, I., Kurosawa, H., Salgado, J., Hugi-MayrCharbonneau, B. E., Barzilai, V. S., Monteiro, V., de Souza, R. R., Harper, M., Suzuki, H., Adams, C., Brieva, J., Nyale, G., Eltatar, F. S., Fatani, J., Baeissa, H., Masri, A. A., Rabie, A., Hui, M. Y., Yamane, M., Jung, H., Margaret, A. M., Nacpil, N., Ruck, K., Bakken, R., Jara, C., Felton, T., Berra, L., Shah, B., Chakraborty, A., Cardona, M., Capatos, G., Akkanti, B., Orija, A., Jain, H., Ito, A., Housni, B., Low, S., Iihara, K., Chavez, J., Ramanathan, K., Zabert, G., Naidoo, K., Seppelt, I., Vandyk, M., Macdonald, S., Mcgregor, R., Siebenaler, T., Flynn, H., Lofton, K., Aokage, T., Shigemitsu, K., Moscatelli, A., Fiorentino, G., Baumgaertel, M., Mba, S. E., Assy, J., Hutahaean, A., Roush, H., Sichting, K. A., Alessandri, F., Burns, D., Salt, G., Garabedian, C. P., Millar, J., Sim, M., Mattke, A., Mcauley, D., Tadili, J., Frenzel, T., Bar-Lavie, Y., Ortiz, A. B., Stone, J., Attokaran, A., Farquharson, M., Patel, B., Gunning, D., Baillie, K., Watson, P., Tamai, K., Sajinadiyasa, G. K., Kanyawati, D., Salgado, M., Sassine, A., Yudo, B., Mccaul, S., Lee, B., Lee, S. M., Afek, A., Iwashita, Y., Semedi, B. P., Metiva, J., Van Belle, N., Martin-Loeches, I., Ivatt, L., Woon, C. Y., Kang, H. M., Smith, T., James, E., Al-Rawas, N., Iwasaki, Y., King-Chung, K. C., Gudzenko, V., Hugi-Mayr, B., Taccone, F., Perdhana, F., Lamarche, Y., Ribeiro, J. M., Bradic, N., Van den Bossche, K., Lansink, O., Singh, G., Debeuckelaere, G., Stelfox, H. T., Yi, C., Elia, J., Tribble, T., Shankar, S., Padmanabhan, R., Hallinan, B., Paoletti, L., Leyva, Y., Fykuda, T., Badulak, J., Koch, J., Hackman, A., Janowaik, L., Hernandez, D., Osofsky, J., Donadello, K., Lawang, A., Fine, J., Davidson, B., Vazquez, A. O. R., COVID-19 Critical Care Consortium, and Consortium, COVID-19 Critical Care

Subjects
Male, Respiratory Distress Syndrome, COVID-19, Intensive care unit, Mechanical ventilation, Neuromuscular blocking agent, SARS-CoV-2, Aged, Female, Humans, Intensive Care Units, Middle Aged, Propensity Score, Respiration, Artificial, Neuromuscular Blocking Agents, Respiration, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Settore MED/41 - Anestesiologia, Critical Care and Intensive Care Medicine, COVID-19 Drug Treatment, Artificial, Human medicine
Abstract

Background The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impact of early use of NMBAs on 90-day mortality, through propensity score (PS) matching analysis. Methods We analyzed a convenience sample of patients with COVID-19 and moderate-to-severe ARDS, admitted to 244 intensive care units within the COVID-19 Critical Care Consortium, from February 1, 2020, through October 31, 2021. Patients undergoing at least 2 days and up to 3 consecutive days of NMBAs (NMBA treatment), within 48 h from commencement of IMV were compared with subjects who did not receive NMBAs or only upon commencement of IMV (control). The primary objective in the PS-matched cohort was comparison between groups in 90-day in-hospital mortality, assessed through Cox proportional hazard modeling. Secondary objectives were comparisons in the numbers of ventilator-free days (VFD) between day 1 and day 28 and between day 1 and 90 through competing risk regression. Results Data from 1953 patients were included. After propensity score matching, 210 cases from each group were well matched. In the PS-matched cohort, mean (± SD) age was 60.3 ± 13.2 years and 296 (70.5%) were male and the most common comorbidities were hypertension (56.9%), obesity (41.1%), and diabetes (30.0%). The unadjusted hazard ratio (HR) for death at 90 days in the NMBA treatment vs control group was 1.12 (95% CI 0.79, 1.59, p = 0.534). After adjustment for smoking habit and critical therapeutic covariates, the HR was 1.07 (95% CI 0.72, 1.61, p = 0.729). At 28 days, VFD were 16 (IQR 0–25) and 25 (IQR 7–26) in the NMBA treatment and control groups, respectively (sub-hazard ratio 0.82, 95% CI 0.67, 1.00, p = 0.055). At 90 days, VFD were 77 (IQR 0–87) and 87 (IQR 0–88) (sub-hazard ratio 0.86 (95% CI 0.69, 1.07; p = 0.177). Conclusions In patients with COVID-19 and moderate-to-severe ARDS, short course of NMBA treatment, applied early, did not significantly improve 90-day mortality and VFD. In the absence of definitive data from clinical trials, NMBAs should be indicated cautiously in this setting.

Published
2022
Full Text
View/download PDF

124. Teaching Effectively with Visual Effect in an Image-Processing Class.

Author

Ng, G. S.

Abstract

Describes a course teaching the use of computers in emulating human visual capability and image processing and proposes an interactive presentation using multimedia technology to capture and sustain student attention. Describes the three phase presentation: introduction of image processing equipment, presentation of lecture material, and demonstration of image processing using an "edge detection and thinning" algorithm. (PEN)

Published
1997

125. The Effect of Visual Impairment on the Strength of Children's Hip and Knee Extensors.

Author

Wyatt, L. and Ng, G. Y.

Abstract

A test of 32 children's hip and knee extensors found that children born blind or with low vision are at risk of developing weak lower-limb extensors, with congenitally blind children at greatest risk. After correcting for lean body weight, the differences between sighted children and those with low vision were insignificant. Results support the value of early physical intervention. (Author/DB)

Published
1997

128. Simultaneous Whole-Chamber Non-contact Mapping of Highest Dominant Frequency Sites During Persistent Atrial Fibrillation: A Prospective Ablation Study

Author

Chu, Gavin S., primary, Li, Xin, additional, Stafford, Peter J., additional, Vanheusden, Frederique J., additional, Salinet, João L., additional, Almeida, Tiago P., additional, Dastagir, Nawshin, additional, Sandilands, Alastair J., additional, Kirchhof, Paulus, additional, Schlindwein, Fernando S., additional, and Ng, G. André, additional

Published
2022
Full Text
View/download PDF

133. Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction—UK multicentre collaboration

Author

Ng, G Andre, primary, Mistry, Amar, additional, Newton, Michelle, additional, Schlindwein, Fernando Soares, additional, Barr, Craig, additional, Bates, Matthew GD, additional, Caldwell, Jane, additional, Das, Moloy, additional, Farooq, Mohsin, additional, Herring, Neil, additional, Lambiase, Pier, additional, Osman, Faizel, additional, Sohal, Manav, additional, Staniforth, Andrew, additional, Tayebjee, Muzahir, additional, Tomlinson, David, additional, Whinnett, Zachary, additional, Yue, Arthur, additional, and Nicolson, Will B, additional

Published
2022
Full Text
View/download PDF

138. Variations in documentation of atrial fibrillation predicted by population and service level characteristics in primary health care in England.

Author

Routen, Ash, Abner, Sophia, Levene, Louis S, Gillies, Clare L L, Davies, Melanie, Seidu, Samuel, Ng, G André, and Khunti, Kamlesh

Subjects
INFERENTIAL statistics, CONFIDENCE intervals, CROSS-sectional method, MULTIPLE regression analysis, ATRIAL fibrillation, DOCUMENTATION, RESEARCH funding, DESCRIPTIVE statistics
Abstract

Background Identifying features associated with atrial fibrillation (AF) documentation could inform screening. This study used published data to describe differences in documented and estimated AF prevalence in general practices, and explored predictors of variations in AF prevalence. Methods Cross-sectional study of 7318 general practices in England. Descriptive and inferential statistics were undertaken. Multiple linear regression was used to model the difference between estimated AF and documented AF, adjusted for population, practice and practice performance variables. Results Documented AF prevalence was lower than estimated (− 0.55% 95% confidence intervals, −1.89, 2.99). The proportion of variability accounted for in the final regression model was 0.25. Factors positively associated with AF documentation (increase in difference between estimated and documented), were patients 65–74 years, 75 years +, Black or South Asian ethnicity, diabetes mellitus and practices in East and Midlands of England. Eight variables (female patients, deprivation score, heart failure and peripheral artery disease, total patients per practice, full-time GPs and nurses; and location in South of England) were negatively associated with AF documentation (reduction in difference). Conclusion Variations in AF documentation were predicted by several practice and population characteristics. Screening could target these sources of variation to decrease variation and improve AF documentation. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

143. Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial

Author

Metzner, Andreas, primary, Suling, Anna, additional, Brandes, Axel, additional, Breithardt, Günter, additional, Camm, A John, additional, Crijns, Harry J G M, additional, Eckardt, Lars, additional, Elvan, Arif, additional, Goette, Andreas, additional, Haegeli, Laurent M, additional, Heidbuchel, Hein, additional, Kautzner, Josef, additional, Kuck, Karl-Heinz, additional, Mont, Luis, additional, Ng, G Andre, additional, Szumowski, Lukasz, additional, Themistoclakis, Sakis, additional, van Gelder, Isabelle C, additional, Vardas, Panos, additional, Wegscheider, Karl, additional, Willems, Stephan, additional, and Kirchhof, Paulus, additional

Published
2021
Full Text
View/download PDF

144. Unsupervised classification of dimension-reduced principal component scores from persistent atrial fibrillation electrograms

Author

Nadim, Asif, primary, Li, Xin, additional, Chu, Gavin, additional, Soriano, Diogo, additional, Masè, Michela, additional, Ravelli, Flavia, additional, Bezerra, Arthur S., additional, Yoneyama, Takashi, additional, Stafford, Peter, additional, Ng, G. André, additional, Schlindwein, Fernando, additional, and Almeida, Tiago, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results